1 |
Alafaci C, Salpietro F, Grasso G, Sfacteria A, Passalacqua M, Morabito A, et al. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. Eur J Pharmacol 2000;406:219-25
DOI
ScienceOn
|
2 |
Akisu M, Tuzun S, Arslanoglu S, Yalaz M, Kultursay N. Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants. Acta Med Okayama 2001;55:357-62
PUBMED
ScienceOn
|
3 |
Kling PJ, Winzerling JJ. Iron status and the treatment of the anemia of prematurity. Clin Perinatol 2002;29:283-94
DOI
ScienceOn
|
4 |
Cataltepe O, Vannucci RC, Heitjan DF, Towfighi J. Effect of status epilepticus on hypoxic-ischemic brain damage in the immature rat. Pediatr Res 1995;38:251-7
PUBMED
ScienceOn
|
5 |
Feng Y, LeBlanc MH, LeBlanc EB, Parker CC, Fratkin JD, Qian XB, et al. Desmethyl tirilazad improves neurologic function after hypoxic ischemic brain injury in piglets. Crit Care Med 2000;28:1431-8
DOI
ScienceOn
|
6 |
Legssyer R, Geisser P, McArdle H, Crichton RR, Ward RJ. Comparison of injectable iron complexes in their ability to iron load tissues and to induce oxidative stress. Biometals 2003;16:425-33
DOI
ScienceOn
|
7 |
Liachenko S, Tang P, Xu Y. Deferoxamine Improves Early Postresuscitation Reperfusion After Prolonged Cardiac Arrest in Rats. J Cereb Blood Flow Metab 2003;23:574-81
DOI
ScienceOn
|
8 |
Barker DJ, Eriksson JG, Forsen T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002;31:1235-9
DOI
ScienceOn
|
9 |
Blanco LN, Frank L. The formation of alveoli in rat lung during the third and fourth postnatal weeks: effect of hyperoxia, dexamethasone, and deferoxamine. Pediatr Res 1993;34:334-40
PUBMED
ScienceOn
|
10 |
Saugstad OD. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin Neonatol 2003;8:39-49
DOI
ScienceOn
|
11 |
Aydin A, Genc Kurdad, Akhisaroglu M, Yorukoglu Kutsal, Gokmen Necati, Gonullu Erdem. Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury. Brain Dev 2003;27:494-8
DOI
ScienceOn
|
12 |
Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 2001;98:4044-9
DOI
ScienceOn
|
13 |
Juul S. Recombinant erythropoietin as a neuroprotective treatment : in vitro and in vivo models. Clin Perinatol 2004; 31:129-42
DOI
PUBMED
ScienceOn
|
14 |
Buonocore G, Perrone S, Longini M, Paffetti P, Vezzosi P, Gatti MG, et al R. Non protein bound iron as early predictive marker of neonatal brain damage. Brain 2003;126:1224-30
DOI
PUBMED
ScienceOn
|
15 |
Catania MA, Marciano MC, Parisi A, Sturiale A, Buemi M, Grasso G, et al. Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur J Pharmacol 2002;437:147-50
DOI
ScienceOn
|
16 |
Spandou E, Papadopoulou Z, Soubasi V, Karkavelas G, Simeonidou C, Pazaiti A, et al. Erythropoietin prevents long- term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res 2005;1045:22-30
PUBMED
ScienceOn
|
17 |
Buonocore G, Perrone S. Biomarkers of hypoxic brain injury in the neonate. Clin Perinatol 2004;31:107-16
DOI
ScienceOn
|
18 |
Weber A, Dzietko M, Berns M, Felderhoff-Mueser U, Heinemann U, Maier RF, et al. Neuronal damage after moderate hypoxia and erythropoietin. Neurobiol Dis 2005;20:594- 600
DOI
ScienceOn
|
19 |
Celik M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc Natl Acad Sci U S A 2002;99:2258-63
DOI
ScienceOn
|
20 |
Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T, Gassmann M. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab 2001;21:857-64
DOI
ScienceOn
|
21 |
Shadid M, Moison R, Steendijk P, Hiltermann L, Berger HM, van Bel F. The effect of antioxidative combination therapy on post hypoxic-ischemic perfusion, metabolism, and electrical activity of the newborn brain. Pediatr Res 1998;44:119-24
DOI
ScienceOn
|
22 |
Yu X, Shacka JJ, Eells JB, Suarez-Quian C, Przygodzki RM, Beleslin-Cokic B, et al. Erythropoietin receptor signalling is required for normal brain development. Development 2002; 129:505-16
PUBMED
ScienceOn
|
23 |
Juul SE, Yachnis AT, Christensen RD.Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 1998;52:235-49
DOI
ScienceOn
|
24 |
Romsi P, Ronka E, Kiviluoma K, Vainionpaa V, Hirvonen J, Mennander A, et al. Potential neuroprotective benefits of erythropoietin during experimental hypothermic circulatory arrest. J Thorac Cardiovasc Surg 2002;124:714-23
DOI
ScienceOn
|
25 |
Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989;140:531-54
ScienceOn
|
26 |
Grow J, Barks J. Pathogenesis of hypoxic-ischemic cerebral injury in the term infant : current concepts. Clin Perinatol 2002;29:585-602
DOI
ScienceOn
|
27 |
Vamvakas EC, Strauss RG. Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion 2001;41:406-15
DOI
ScienceOn
|